Abstract Athletes have higher bone mineral density (BMD) relative to nonathletes. In amenorrheic athletes BMD may be compromised by estrogen deficiency, but it is unknown whether this is accompanied by structural differences. We compared femoral neck bone geometry and density of a-/oligomenorrheic athletes (AAs), eumenorrheic athletes (EAs), and eumenorrheic controls (ECs). We recruited 156 women: (68 endurance athletes and 88 controls). Femoral neck BMD, section modulus (Z), and width were measured using dual-energy X-ray absorptiometry. Menstrual function was assessed by questionnaire and classified as EA (C10 periods/year) or AA (B9 periods/year): 24 athletes were AA and 44 EA. Femoral neck BMD was significantly higher in EA than AA (8 %, difference) and EC (11 % difference): mean ; p \ 0.001. Femoral neck width did not differ between groups. All differences persisted after adjustment for height, age, and body mass. The higher femoral neck Z and BMD in athletes, despite similar width, may indicate that exercise-related bone gains are endosteal rather than periosteal. Athletes with amenorrhea had smaller increments in bone mass rather than structural adaptation. The maintained femoral neck width in controls may be an adaptive mechanism to conserve bone strength in bending despite inactivity-related bone decrement.
Introduction
Athletes have higher bone mineral density (BMD) than controls, but amenorrheic athletes (AAs) have substantially lower BMD at the lumbar spine and femoral neck than their regularly menstruating peers [1] [2] [3] [4] [5] . Estrogen deficiency in AAs may promote low bone mass [6] , although the effect of estrogen deficiency on bone strength is unknown.
BMD has been used as a proxy for bone strength [7, 8] . However, bone strength encompasses the bone's architecture, geometry, cortical porosity, and tissue mineralization, which cannot be individually identified in BMD measurements [9] , although some of these factors may contribute to BMD. Therefore, it is important to consider structural determinants of bone strength such as section modulus (Z), a measure of strength in bending. This can be calculated using bone densitometry in the form of hip structural analysis.
Exercise may affect structural parameters and have BMD-independent influences on bone strength [10] . Estrogen deficiency also seems to influence bone structure, based on studies in animals and observations in postmenopausal women [11, 12] . Exercise has previously been shown to enhance the bone's accrual on the periosteal (outer) surface, thus conferring greater resistance to bending, whereas estrogen may inhibit periosteal apposition [12] . In eumenorrheic women, exercise may be a potential preventive measure for osteoporotic fractures as the increased highimpact loads can lead to increases in BMD relative to sedentary women [13, 14] . However, in AAs, estrogen deficiency is related to bone loss, raising concerns about increased risk of future osteoporosis [11, 12] . The effect of estrogen deficiency on bone strength will, however, depend on the location of bone loss. It is possible that in AAs the low BMD is accompanied by structural differences such as increased bone diameter that would preserve Z and strength in bending [11] . Conversely, if the BMD decrement is from the periosteal surface, Z may be reduced to a greater extent than BMD. The effect of amenorrhea on bone strength thus depends upon the location of the bone decrement, and this is currently unknown.
While it is accepted that exercise and estrogen are beneficial to bone density [12, 15] , the effects of estrogen deficiency on bone structural parameters in athletes are unknown. It is possible that differences in bone strength between AAs and eumenorrheic athletes (EAs) are different from those that would be predicted based upon BMD alone. Thus, the aim of this study was to compare bone geometry and density of AAs, EAs, and eumenorrheic controls (ECs).
Methods

Study Design
A cross-sectional design was used to compare bone status in female endurance athletes and sedentary controls according to menstrual function. BMD, bone mineral content (BMC), and body composition were assessed using dual-energy X-ray absorptiometry (DXA). DXA was also used to estimate bone geometric parameters using the advanced hip structural analysis (AHA) software. Questionnaires were completed to assess current and past menstrual function. Bone parameters were compared between ECs with no history of menstrual dysfunction and athletes classified according to current menstrual function as eumenorrheic (EA) or a-/oligomenorrheic (AA). To allow a comparison based upon cumulative exposure to estrogen deficiency, athletes were also classified according to menstrual history as regularly menstruating (RMA) or irregularly menstruating (IMA). Ethical approval was received from the National Research Ethics Service and the Loughborough University Ethics Committee. All participants gave written consent.
Subjects
We recruited 68 female endurance athletes (57 runners and 11 triathletes) and 88 healthy sedentary controls, aged 18-45 years. Athletes were recruited from sporting federations and registered running and triathlon clubs within the United Kingdom. They were required to be competing at an elite level for their age and/or training at a high volume (8-10 h/week for a runner and 15-20 h/week for a triathlete) in events from 800 m to the marathon or triathlon. Athletes were excluded if they had any injury that affected their training in the previous 12 months. Athletes and controls were excluded if they had been pregnant or lactating in the past 12 months; if they had commenced, ceased, or changed hormonal contraception use within the previous 12 months; or if they had any medical conditions or were taking medications which were likely to affect bone metabolism. The 88 controls were recruited within the Loughborough community for a previous intervention study, the aim of which was to determine the optimal weekly frequency of exercise to increase bone mass in premenopausal women who do not regularly participate in physical activity [16] . Baseline measurements are reported here. Controls were screened to exclude individuals who had a body mass index [30 kg/m 2 , participated in highimpact or weight-bearing exercise for more than 1 h/week, or were not regularly menstruating (\10-13 menstrual cycles/year) [16] .
BMD and Geometry
DXA was used to measure BMD and BMC of the lumbar spine (L1-L4) and femoral neck. Bone geometric properties of the femoral neck were estimated using the AHA software (Lunar Prodigy, version encore 12.2; GE Healthcare, Madison, WI) to determine cross-sectional area (CSA), Z, minimal neck width, and strength index. Femoral strength index is the ratio of estimated compressive yield strength of the femoral neck to the expected compressive stress of a fall on the greater trochanter adjusted for the patient's age, height, and weight. This is estimated from Z but incorporates other variables also [17, 18] .
Menstrual Function
Questionnaires were used to assess current and past menstrual function and hormonal contraceptive use. Participants were classified into three groups: AA (B9 periods/ year), EA (including those taking hormonal contraception, C10 periods/year), and EC. Participants who reported changes in hormonal contraception use in the previous 12 months were excluded from the study.
Fasted serum samples (not synchronized to menstrual cycle) were collected. As a high prevalence of polycystic ovary syndrome (PCOS) has been reported in female athletes [19, 20] , serum samples were analyzed for anti-mullerian hormone (AMH) to differentiate hypothalamic amenorrhea from PCOS and premature ovarian failure: AMH is elevated in PCOS but does not vary over the menstrual cycle [21] . Analysis was conducted using a generation II ELISA kit (Beckman Coulter, High Wycombe, UK). Any athlete identified as having elevated AMH values ([67.1 pmol/L) was excluded from this study.
Calculation of Menstrual Index in Athletes
Menstrual index (MI) was calculated using the equation derived by Grimston et al. [22] , to provide a summary measure of menstrual history in female athletes, which may involve changes in menstrual function (amenorrhea, oligomenorrhea, and amenorrhea) over a life span. Athletes were asked to record their age at menarche (M) and the number of years they had been amenorrheic (0-3 periods/ year) and oligomenorrheic (4-10 periods/year) since menarche. MI was calculated using the following equation:
MI represents the average menses per year over the entire length of menstruation; 11.5, 7, and 1.5 represent the annual menstrual frequency in years at midpoints of the menstrual categories eumenorrhea, oligomenorrhea, and amenorrhoea, respectively; M represents age at menarche; and C is current age.
Based on the MI categories derived by Grimston et al. [22] , athletes were categorized into two groups: athletes with a history of menstrual regularity, MI C10 (RMA), and athletes with a history of menstrual irregularity, MI \10 (IMA).
Anthropometric Measures
Height and body mass were assessed with standard protocols using a stadiometer and a beam balance scale, respectively, in all participants. Body composition in athletes was assessed using DXA.
Statistical Analysis
Descriptive statistics (mean and standard errors) were used to characterize the sample. Analysis of variance (ANOVA) was used to compare means between menstrual function groups, with a Tukey's post hoc test to determine which groups differed. An analysis of covariance was used to adjust for age, height, and body mass. All statistical analyses were carried out using SPSS 16.0 (SPSS, Inc., Chicago, IL). The level of significance was set at p \ 0.05.
Results
The physical characteristics of the three groups can be found in Table 1 Nineteen (43 %) of the EAs were currently taking hormonal contraception. According to the MI, 26 (40 %) athletes, but none of the controls, had a history of irregular menstruation. Three athletes did not provide adequate information to determine menstrual history using the MI.
ECs had significantly lower height and greater age and weight than both athlete groups, whether athletes were classified according to current menstrual function or menstrual history ( 
Bone Geometry
Bone geometric properties estimated at the hip using DXA are summarized in Table 2 . Femoral neck CSA was significantly higher in EAs compared to AAs and ECs (9 and 11 % difference, respectively; p \ 0.001), similar to the femoral neck BMD. Z was significantly higher in EAs than ECs (11 % difference, p = 0.001). The strength index of the bone was significantly higher in EAs and AAs than ECs (23 and 14 % difference, respectively; p \ 0.001) (Fig. 1 ).
There were no significant differences in geometric properties (Z, strength index, and minimal neck width) between the AA and EA groups (Z 6 %, p = 0.272; strength index 9 %, p = 0.128; and minimal neck width 2 %, p = 0.655). 
BMD and Bone Geometry According to MI
To examine whether bone properties differed according to estrogen exposure across the reproductive period, 65 of the athletes were regrouped according to MI. Three of the athletes were excluded from the analysis as they provided incomplete information. Results were generally similar to those from the current menstrual function analysis at the lumbar spine, with those athletes reporting a history of IMA (n = 26, MI \ 10) having significantly lower lumbar spine (L1-L4) BMD than RMA athletes (9 % difference, p = 0.007) and the EC group (11 % difference, p \ 0.001). In contrast to the findings according to current menstrual function, lumbar spine (L1-L4) BMC was significantly lower in the IMA than the RMA group (6 % difference, p = 0.026). IMAs had significantly higher CSA (6 % difference, p = 0.045) and strength index (20 % difference, p \ 0.001) than ECs. Similarly, RMAs had significantly higher femoral neck BMD (10 % difference, p \ 0.001), CSA (9 % difference, p \ 0.001), Z (11 % difference, p = 0.002), and strength index (16 % difference, p \ 0.001) than ECs; but in contrast to the findings according to current menstrual function, femoral neck BMD and CSA did not differ significantly between the athlete groups ( Table 2) .
Adjustments for Differences in Physical Characteristics
After adjustment for age, body mass, and height, similar significant differences in BMD, BMC, and bone geometric properties at the femoral neck according to current menstrual function persisted. When comparing groups according to menstrual history, the athlete groups showed significantly higher BMD after adjustments for physical characteristics (IMA 2 ; p \ 0.05) at the femoral neck than ECs. At the lumbar spine, differences in BMD according to current menstrual function were no longer significant but RMAs still had a significantly higher BMD at the lumbar spine compared to IMAs.
Discussion
This study is novel in that it compares bone geometry according to menstrual function in female endurance athletes and sedentary controls. AAs had lower BMD compared to EAs, but this was still higher than that in ECs. Z showed a similar magnitude of differences between groups as BMD. Femoral neck width was similar in all groups, suggesting that the higher BMD and BMC in athletes are related to additional endosteal or trabecular bone, rather than periosteal apposition.
Menstrual dysfunction was prevalent in this sample of athletes, with 24 (35 %) reporting current menstrual dysfunction and 40 % reporting a history of menstrual dysfunction when calculated as MI. These findings are consistent with previous reports which have indicated menstrual dysfunction in 1-44 % [23] of athletes depending on the sport population surveyed and the definition of ''menstrual dysfunction'' [23, 24] . Contrary to some previous findings [25] , there were no significant differences in height, body mass, and age between AAs and EAs, although the sedentary control group was significantly older, heavier, and shorter than the athlete groups.
Athletes had a significantly higher femoral neck BMD than the sedentary ECs, in accordance with earlier studies [11, 13, 14, 23, 26] . Torstveit and Sundgot-Borgen [26] found that low BMD was three times more likely in nonathletes than in athletes, with athletes having 3-20 % higher BMD compared to nonathlete controls. In the present study EAs had approximately 14 % higher BMD than controls after adjustments for age, height, and weight. AAs had intermediate values, with mean BMD 8 % lower than that in EAs but 2 % higher than that in controls. Prolonged exercise may thus partly counteract the skeletal effects of prolonged estrogen deficiency [11, 12, 24] . Similarly, gymnasts, who engage in a higher-impact activity, have greater BMD than normally active individuals despite later menarche and periods of amenorrhea [24, 27] .
The differences in BMD observed here may not entirely represent the differences in bone strength between groups as exercise and estrogen deficiency may have structural effects that influence bone strength independently of BMD. This study is the first to examine the effects of amenorrhea on hip geometric parameters, such as section modulus, related to strength in bending. EAs had significantly greater Z compared with ECs, which persisted after adjustment for weight, height, and age. The decrement in Z in AAs compared to EAs was of similar magnitude as that for femoral neck BMD (6 vs. 8 %) but was not statistically significant (p = 0.272). As with BMD, Z was not lower in AAs compared to regularly menstruating controls. A previous study in anorexic women with secondary amenorrhea found that low BMD relative to controls was accompanied by lower structural properties (Z, cortical thickness); hence, the bone's resistance to bending was compromised at the hip compared to healthy controls [28] . The AAs in this study had a greater duration of amenorrhea than the anorexic women in the study of DiVasta et al. [28] , so the differences in BMD seem likely to be due to differences in skeletal loading, lean mass, and possibly other nutritional or endocrine deficiencies that may be associated with anorexia.
There were no significant differences in femoral neck width between any of the groups, although both exercise [11] and estrogen deficiency [29] have been suggested to enhance periosteal expansion. Exercise has been reported to increase bone diameters at the tibia and radius [30, 31] , but bone width at the femoral neck did not differ between athletes engaging in different types of sports and controls [32] . The discrepancy between studies may be explained by differences in loading between these skeletal sites, with more torsional loading at the tibia and radius. Previous findings in estrogen-deficient women have been consistent with estrogen deficiency promoting periosteal expansion. In adolescents with anorexia, bone outer diameter was maintained despite a substantial decrement in bone density and CSA relative to controls [28] . In postmenopausal women, periosteal diameter increased most rapidly in those with the highest sex hormone binding globulin values (hence presumably lower bioavailable estradiol) [33] . However, differences were only 0.03 mm/year, so it is possible that the duration of amenorrhea and/or exercise in this study was not great enough to have yielded detectable differences in femoral neck width.
To have higher BMC and BMD at the femoral neck with the same bone width implies that differences are related to either endocortical or trabecular bone. The fact that Z is higher in the athletes may make endocortical increments seem more likely. However, the study is crosssectional and, thus, may be affected by selection bias. For runners, lightness offers a competitive advantage, so women with smaller skeletal size and mass may be more likely to succeed. It is possible that if athletes had not exercised, they would have had a smaller neck width than the controls consistent with lower body mass. It is therefore possible that exercise-associated periosteal apposition has counteracted an otherwise smaller neck width in athletes.
Although femoral neck BMD was significantly higher in athletes, lumbar spine BMD was highest in the sedentary controls, though differences were not significantly significant after adjustments for age, height, and weight. Athletes with a history of amenorrhea had significantly lower spine BMD than their regularly menstruating peers, although there were no significant differences according to current menstrual function. Previous studies have reported lower lumbar spine BMD in AAs than EAs [13, [34] [35] [36] . The lumbar spine may be more responsive to hormonal stimuli than the femoral neck due to the higher ratio of trabecular (62-70 %) to cortical (30-38 %) bone [23] , so theoretically it may be more susceptible to estrogen deficiencyrelated bone loss. That lumbar spine BMD differed according to MI rather than current amenorrhea may suggest that cumulative estrogen exposure is most important. Another possible explanation is that many of the AAs in this study took part in resistance training, which may compensate for potential estrogen deficiency-related losses in BMD at the lumbar spine by increased loading [26] and, thus, may explain the observed preservation of the lumbar spine BMD.
The limitations of this study include that bone geometric properties were estimated at the hip using AHA, which provides only a 2-dimensional image in one plane. Differences in positioning of the femoral neck could result in changes in the measure of the geometric properties of the hip. In order to achieve a more accurate measure of bone geometry, a 3-dimensional image would be preferable, such as that given by CT or pQCT. However, in a sample of women of reproductive age there may be ethical concerns about the radiation dose required for hip CT measurement. Menstrual status was assessed retrospectively. While amenorrhea is indicative of estrogen deficiency, we did not assess serum or urinary metabolites of estrogen throughout the menstrual cycle [24] , which would have been demanding for participants and was beyond the scope of this investigation. The control group was not matched for age, height, and body mass to the athlete groups, which would have been the optimal study design as matching for body mass may offset the effects of exercise. However, physical characteristics were added as covariates and the findings were not substantially affected, so the different characteristics probably did not contribute to the findings.
The findings from this study may have implications for the clinical and applied sports medicine field, illustrating that the skeletal effects of estrogen deficiency in AAs may be counteracted by loading-induced bone gains. Even though these findings may indicate that AAs who participate in loading sports have some preservation of BMD, we cannot be sure that this adaptation is adequate to withstand the potentially higher levels of loading in this group. It is clear that the bone adaptations seen in EAs are not as pronounced in AAs, therefore potentially conferring greater risk of bone dysfunction. Therefore, it is important to continue to address oligomenorrhea and amenorrhea and its underlying causes in the athletic population.
It can therefore be concluded from this study that EAs have significantly higher femoral neck Z, as well as BMD, than controls. AAs had intermediate values for both parameters, suggesting that amenorrhea limits exerciseinduced bone gains rather than inducing structural adaptation. Femoral neck width was very similar in all groups despite higher BMC in athletes; therefore, the additional bone in athletes may represent more endosteal bone, rather than periosteal apposition. The maintained femoral neck width in controls may be an adaptive mechanism to conserve bone strength in bending despite inactivity-related bone decrement.
